Skip to main content

Table 3 Correlation of EGFR, PIK3CA, KRAS, TP53, and CTNNB1 mutations with clinicopathological features

From: Mutation profile of non-small cell lung cancer revealed by next generation sequencing

Features

 

EGFR mutation

p-value

PIK3CA mutation

p-value

KRAS mutation

p-value

TP53 mutation

p-value

CTNNB1 mutation

p-value

  

No

Yes

Total

 

No

Yes

Total

 

No

Yes

Total

 

No

Yes

Total

 

No

Yes

Total

 

Gender

Male

27

12

39

0.305

38

1

39

0.327

36

3

39

0.620

27

12

39

0.219

39

0

39

0.091

 

Female

19

14

33

 

30

3

33

 

32

1

33

 

27

6

33

 

30

3

33

 

Age

 < 62

24

12

36

0.624

33

3

36

0.303

33

3

36

0.303

25

11

36

0.276

35

1

36

1.000

 

 ≥ 62

22

14

36

 

35

1

36

 

35

1

36

 

29

7

36

 

34

2

36

 

Stage

I–II

30

20

50

0.859

48

2

50

1.000

47

3

50

1.000

36

14

50

0.461

48

2

50

1.000

 

III–IV

10

6

16

 

15

1

16

 

15

1

16

 

13

3

16

 

15

1

16

 

Histology type

ADC

36

25

61

0.059

60

1

61

0.008

57

4

61

1.000

48

13

61

0.053

58

3

61

1.000

 

SqCC

9

1

10

 

7

3

10

 

10

0

10

 

5

5

10

 

10

0

10

 

Smoking status

Non-smokers

26

21

47

0.038

44

3

47

1.000

46

1

47

0.117

39

8

47

0.032

44

3

47

0.547

 

Smokers

20

5

25

 

24

1

25

 

22

3

25

 

15

10

25

 

25

0

25

 
  1. p value by Chi-square or Fisher’s exact test when appropriated
  2. Bold values represent p < 0.05 or borderline